Latin America NGS Market Set to Reach $597.20 Million by 2034 – BIS Research

What Is the Latin America NGS Market Outlook? 

The Latin America NGS market is poised for substantial growth, fueled by the increasing adoption of genomic technologies in clinical diagnostics, research, and personalized medicine. The region's focus on improving healthcare infrastructure and the growing prevalence of chronic diseases are key factors propelling the demand for NGS solutions. Moreover, collaborations between public and private sectors are enhancing access to advanced sequencing technologies, further stimulating market expansion. 

How Fast Is the Latin America NGS Market Growing? 

According to BIS Research, the Latin America NGS market was valued at $268.04 million in 2024 and is projected to reach $597.20 million by 2034, growing at a compound annual growth rate (CAGR) of 8.34% over the forecast period (2024–2034).  

Explore the Full TOC and Download Report Sample    

What New Technologies Are Reshaping the Latin America NGS Market? 

The Latin America NGS market is witnessing rapid technological advancements, including the development of high-throughput sequencing platforms, integration of artificial intelligence in data analysis, and the emergence of portable sequencing devices. These innovations are enhancing the efficiency, accuracy, and accessibility of genomic sequencing, thereby broadening its applications across various sectors such as oncology, infectious diseases, and genetic disorders. 

Demand Drivers, Challenges & Opportunities – What Factors Are Shaping the Latin America NGS Market? 

Drivers: 

• Rising Prevalence of Chronic Diseases: The increasing incidence of cancer and genetic disorders is driving the demand for advanced diagnostic tools like NGS. 
• Government Initiatives: Supportive policies and funding for genomic research are facilitating the adoption of NGS technologies. 
• Technological Advancements: Continuous innovations in sequencing technologies are reducing costs and turnaround times, making NGS more accessible. 

Challenges: 

• High Initial Investment: The substantial capital required for setting up NGS facilities can be a barrier for smaller institutions. 
• Lack of Skilled Professionals: A shortage of trained personnel to operate and interpret NGS data may hinder market growth. 

Opportunities: 

• Expansion into Emerging Markets: Untapped markets within Latin America present significant growth opportunities for NGS providers. 
• Personalized Medicine: The growing emphasis on tailored therapeutic approaches is expected to boost the demand for NGS-based diagnostics.bisresearch.com 

How Is the Latin America NGS Market Segmented? 

Segmentation 1: Offering based segmentation 

•    Instruments: This segment includes integrated workflow instruments, sequencing instruments, and library preparation instruments. 

•    Kits and Consumables: This segment includes library preparation kits, target enrichment kits, sequencing kits, and multi-use kits. 

•    Software 

•    Services 

Based on offering, the services segment is expected to dominate the Latin America NGS market. 

Segmentation 2: Technology based segmentation 

•    Ion Torrent Semiconductor Sequencing 

•    Reversible Terminator Sequencing (SBS) 

•    Single Molecule Real Time Sequencing 

•    Nanopore Sequencing Technologies 

•    Other Technologies: It includes SOLiD sequencing, 10x Genomics' Chromium Technology, etc. 

Based on technology, the reversible terminator sequencing (SBS) segment is expected to dominate the Latin America NGS market. 

Segmentation 3: Application based segmentation 

•    Clinical: It includes oncology, neurological diseases testing, reproductive health testing, rare disease diagnostics, infectious disease testing, and others. 

•    Translational Research: It includes hematologic malignancies and solid tumors. 

Based on application, the clinical segment is expected to dominate the Latin America NGS market. 

Segmentation 4: End User based segmentation 

•    Hospitals and Clinics 

•    Academic and Research Institutes 

•    Pharmaceutical and Biotechnology Companies 

•    Government Labs 

•    Other End Users 

Download the complete TOC now! 

Who Are the Leaders in the Latin America NGS Market? 

Key players operating in the Latin America NGS market include: 

• Illumina, Inc. 
• Thermo Fisher Scientific Inc. 
• QIAGEN N.V. 
• F. Hoffmann-La Roche Ltd. 
• Agilent Technologies, Inc. 

These companies are investing in research and development, strategic partnerships, and regional expansions to strengthen their market presence. 

Strategic Initiatives – What Moves Are Shaping the Future of the Latin America NGS Market? 

Companies are focusing on: 

• Product Innovation: Developing advanced sequencing platforms tailored for the Latin American market. 
• Collaborations: Partnering with local research institutes and healthcare providers to enhance market penetration. 
• Training Programs: Implementing educational initiatives to address the skill gap in NGS operations and data interpretation. 

How Will This Report Help You? 

1. Are you evaluating market entry or expansion strategies? 
2. This report provides regional market insights, helping you pinpoint high-growth countries and emerging areas for investment in the Latin American NGS space. 
3. Looking to identify emerging trends before your competitors do? 
4. Uncover advancements in sequencing technologies, AI-driven bioinformatics, and clinical adoption trends shaping the future of genomics in Latin America. 
5. Planning your next product development or partnership? 
6. Identify key therapeutic areas, unmet diagnostic needs, and application gaps to build a focused innovation pipeline or initiate strategic collaborations. 
7. Want to quantify opportunities in each region? 
8. The report includes market size projections, growth rates, and country-level segmentation to support data-driven decision-making. 

Request sample report on Latin America NGS Market 

Here Are Some Case Studies and Success Stories in the Latin America NGS Market 

Brazil: A national program using targeted NGS panels for hereditary cancer screening enabled early diagnosis, reduced mortality, and cut healthcare costs through a research-genomics company collaboration. 

Mexico: NGS-integrated newborn screening, launched via government–biotech partnerships, identified rare genetic disorders early and advanced the country's precision medicine roadmap. 

Schedule a Call with Industry Experts 

Related Reports from BIS Research 

Middle East Life Sciences Market 

Global Next Generation Implants (NGI) Market 

Next Generation Sequencing (NGS) Market 

About BIS Research 

BIS Research is a global B2B market intelligence and advisory firm focusing on deep technology and related emerging trends, which can disrupt the market dynamics in the near future. We publish over 200 market intelligence studies annually, focusing on several deep technology verticals.   

Our strategic market analysis emphasizes market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management.    

BIS Research offers syndicate and custom studies and expert consultations to firms, providing them with specific and actionable insights on novel technology markets, business models, and competitive landscapes.   

Contact 

Head of Marketing  

Email: media@bisresearch.com    

BIS Research Inc.   

39111 PASEO PADRE PKWY STE 313,   

FREMONT, CA 94538-1686  

Visit our Blog @https://bisresearch.com/insights   

Get Expert Insights @https://community.insightmonk.com    

Connect with us on LinkedIn @ https://www.linkedin.com/company/bis-research    

Connect with us on Twitter@ https://twitter.com/BISResearch